POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer

<strong>Purpose:</strong> Recent studies have shown that 7-12% of endometrial cancers (ECs) are ultramutated due to mutation in the proofreading exonuclease domain of the DNA replicase POLE. Interestingly, these tumors have an excellent prognosis. In view of the emerging data linking mut...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Klenerman, P, Church, D, Tomlinson, I, van Gool, I, Eggink, F, Freeman-Mills, L, Stelloo, E, Marchi, E, de Bruyn, M, Palles, C, Nout, R, de Kroon, C, Osse, E, Creutzberg, C, Smit, V, Nijman, H, Bosse, T
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	American Association for Cancer Research 2015

POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer

Gelijkaardige items